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Introduction
Atherosclerotic cardiovascular disease is the primary cause of morbidity and mortality in the developed world (1, 2) . Unfortunately, due to lack of sensitive and specific early biomarkers, the first clinical presentation of more than half of these patients is either myocardial infarction or death (19, 20) . Moreover, despite appropriate evidence-based treatments, recurrence and mortality rates remain high even among patients with long established atherosclerotic cardiovascular disease.
Inflammation has been implicated in all stages of atherosclerosis (41) (12) (26) and elevated serum inflammatory markers have been shown to stratify cardiovascular risk and assess response to therapy (39, 40) . However, current known inflammatory markers are not expressed primarily in the vascular wall, and hence may lack specificity for vascular disease, increasing false positive findings in the case of non-vascular inflammatory processes. While available inflammatory markers have been shown to predict outcome and response to therapy in large groups of patients with cardiovascular disease, they are not useful in screening for atherosclerotic disease, or more importantly for prediction of the likelihood of a first cardiovascular event at the level of the individual patient (38) . Hence, there is a critical need for identification of inflammatory markers that are more specific to vascular disease and can be used for highly sensitive and specific assays capable of detecting and quantifying atherosclerotic cardiovascular disease. We hypothesize that patterns of multiple circulating disease-related serum biomarkers can accurately predict the severity of atherosclerotic disease.
Mouse genetic models of atherosclerosis allow systematic temporal study of the disease process from its earliest stages and can be used as optimal models for biomarker discovery.
ApoE-deficient mice predictably develop spontaneous atherosclerotic plaques with many features similar to human lesions (31) (32) (36) . On a high-fat diet, the rate and extent of progression of lesions is accelerated. In addition to environmental influences such as diet, the genetic background of mice has also been found to have an important role in disease TEXT_PG-00240-2005-R development and progression (14, 47) . Using parallel longitudinal experiments it is possible to account for these variables (diet, age, and genetic background) and identify differentially expressed proteins with serum levels that correlate with the extent of the vascular disease. In a recent study, we have shown that C57Bl/6 mice are more prone to develop inflammation in response to atherogenic stimuli (47). Using high throughput gene expression studies of the vascular wall in apoE-deficient mice, we have been able to identify a small subset of genes, primarily inflammatory, whose level of transcription can classify vascular disease in both mice and humans (45). These findings are supported by other studies showing the importance of vascular wall expression of chemokines and chemokine receptors in vascular disease (5, 27, 28 ).
To identify patterns of serum protein expression that can be correlated to both disease progression and gene expression in the vascular wall, we have taken advantage of a longitudinal experimental design, and mouse genetic model and diet combinations that produce varying degrees of atherosclerosis. Here, we have utilized a protein microarray to identify a set of inflammatory biomarkers that are differentially expressed in the sera of mice at levels that correlate with various severity levels of disease. The vascular wall gene expression for a subset of these markers was also evaluated by quantitative real-time reverse transcriptase polymerase chain reaction. Using classification algorithms to identify a set of the most sensitive discriminators, we were able to show that unique signature patterns of vascular-derived inflammatory biomarkers can accurately predict different severity of atherosclerotic disease in mice.
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Methods
Experimental design, Serum collection and RNA preparation
All experiments were performed following Stanford University animal care guidelines (42). The general experimental design has been described previously (45). Three week old female apoE knock-out (C57BL/6J-Apoe tm1Unc ), C57Bl/6J, and C3H/HeJ mice were purchased from Jackson Labs (Bar Harbor, ME). At four weeks of age the mice were either continued on normal chow or were fed a high fat diet which included 21% Anhydrous Milkfat and 0.15% Cholesterol (Dyets #101511, Dyets Inc., Bethlehem, PA) for maximum period of 40 weeks. Serum was collected by retro-orbital approach for 5-9 individual mice at every time point for ApoE-deficient mice on high fat diet from the same cohort of mice as described previously. To control for diet and genetic differences, serum was also collected at baseline and 40 weeks from apoE knock-out (C57BL/6J-
Apoe tm1Unc
) on normal chow and from wild-type C57Bl/6J, and C3H/HeJ mice on normal chow and high fat diets. Aortas from 15 mice (3 pools of 5) were harvested for RNA isolation as described previously (45) at each of the time-points for each of the conditions (strain-diet combination) to parallel serum collection schedule. Total RNA was isolated as described previously using a modified two-step purification protocol (45, 47). Quantification of aortic atherosclerotic plaque (determined as percent lesion area in entire aorta) has been previously performed on this cohort of mice and described in a prior publication (45). Serum and aortas from a separate independent cohort of sixteen week old apoE-deficient mice on high fat diet for two weeks (4 pools of 3-4 animals) were also used for classification purposes. The rationale for pooling RNA and serum samples for microarray hybridizations has been discussed previously (45-47, 49). All sample processing and protein hybridization were performed at the same time to negate any potential technical variability.
Protein Biochip hybridization and Data processing TEXT_PG-00240-2005-R
Serum samples were hybridized to Zyomyx Murine Cytokine BioChips (Zyomyx, Hayward, CA) following manufacture's instructions, using the Zyomyx 1200 Assay station (Zyomyx, Hayward, CA). Nine point calibration curves were generated for each analyte for accurate determination of protein levels in test sera (please see supplement 4 for individual calibration curves). Protein biochips were scanned using a Zyomyx 100 Fluorescence scanner and microarray gridding was performed using GenPix Pro and Zyomyx ZDR version 4001 software. Intra-chip (ratio of standard deviation of all negative control features over the average intensity for those features) and interchip variability (ratio of average standard deviation over average of median intensities) were determined as measures of quality control. Protein arrays present control variability ranging from 3 to about 15 % and sensitivity from 1 to 1000 pg/ml depending on the analyte (please see supplemental calibration curves for each analyte) (11) . Values that were not in the linear portion of the calibration curves were marked as missing values. Numerical raw data were then migrated into an Oracle relational database (CoBi) that has been designed specifically for microarray data analysis (GeneData, Inc.). Heat maps were generated using "HeatMap Builder" software (7).
Detailed supplemental methods are provided online on the publisher's website.
Protein selection algorithms and disease classification:
Protein selection and classification algorithms have been described previously (45). Briefly, for supervised analyses we used the Expressionist software v.5.0 (GeneData USA) which employs a number of classification algorithms to rank genes based on their utility for class discrimination between time points 0, 10, 24, and 40 weeks in apoE mice on high-fat diet. These algorithms included Analysis of variance (ANOVA), Support Vector Machine (SVM) (4), and Recursive Feature Elimination (RFE) (16) which is a recursive version of the SVM weight where genes are ranked repeatedly and a fixed fraction of worst scorers are removed each time (35) . We also used the previously described Prediction Analysis of Microarray (PAM) as an additional classification algorithm (48). Each method was then used to determine the optimal number of ranked genes to
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classify the experiments into their correct groups at minimal error rate. The optimal error rate or misclassification was calculated by cross-validation with 25% of the experiments as the test group and the rest as the training group. This was reiterated 1000 times for ANOVA, SVM, and RFE algorithms. In our analyses we used a linear Kernel for SVM and RFE; a nonlinear Gaussian kernel yielded similar results. This minimal subset of classifier genes was then used for crossvalidation as well as classification of another independent dataset. Detailed methods are described online on the publisher's website.
Cross validation and Analysis of independent datasets. To determine the accuracy of classification based on the small subset of proteins identified earlier, we utilized the SVM algorithm (Linear Kernel) to generate a confusion matrix using cross validation with repeated splits into 75% training and 25% test sets. Results are represented in tabular fashion. We also utilized the SVM algorithm for classification of independent groups of experiments as described previously (45, 50). In this analysis we used the 4 time points in apoE-deficient mice as the training set and the independent set of experiments as the test set. SVM output for each experiment based on one-versus-all comparisons were represented graphically in a heatmap format (Fig 3) which is the normalized margin value for each of the 4 SVM classifiers mentioned above. The SVM output allows us to view how a new experiment is classified according to the 4 SVM hyperplane. Detailed methods are described online on the publisher's website.
Quantitative real-time reverse transcriptase polymerase chain reaction
Primers and probes for 10 genes of interest were obtained from Applied Biosystems Assays-onDemand for Taqman analysis (Supplemental Table 1 ). Reactions were performed in triplicate assays using representative RNA samples derived from three pools of five aortas as described previously (45-47).
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Results
Temporal patterns of protein expression during atherogenesis in apoE-deficient mice
We have demonstrated previously the extent of atherosclerotic lesions in this cohort of apoE deficient mice (45). Given the extensive atherosclerotic lesions in the aorta as well as the aortic valve of the apoE-deficient mice, other vascular beds were not examined in these studies. To identify serum markers that correlate with extent of atherosclerotic lesions we have utilized a protein microarray to simultaneously measure the serum level of thirty inflammatory markers in apoE-deficient mice on high fat diet throughout the time-course of disease development. For control groups we utilized the apoE deficient mice on normal diet as well as wild-type C57Bl/6J and C3H/HeJ mice at two time points. Eight out of the thirty markers measured did not reveal significant serum expression levels (Please see supplement table 2 for the entire dataset).
Twenty-two markers revealed unique time-related patterns of expression, some of which closely correlated with the extent of atherosclerotic lesions in the aorta previously described in this cohort of mice ( 
Strain-specific protein expression with high-fat diet and aging
To account for atherosclerosis-independent variation in serum protein levels due to high-fat diet, aging, and genetic background we used a number of controls including two previously well studied mouse strains with different propensities to develop atherosclerosis, two different diets, and a longitudinal experimental design. We have shown previously that these control mice did not
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develop atherosclerotic lesions, and thus were appropriate controls to account for these independent variables and possible interactions among them. As a result we were able to identify differentially expressed proteins that are likely to be related to each variable and distinguish those specifically related to vascular disease processes in the apoE-deficient model.
Simple analysis of variance (ANOVA) revealed that at least 12 markers that were differentially expressed among the various diet-strain-time combinations (Fig. 2) . To account for possible interaction among the 3 independent variables we utilized 3-way ANOVA. Three independent variables have three first order interactions (time-strain, time-diet, strain-diet) and one-second order interaction (time-strain-diet). Accounting for interaction among all three factors identified five proteins as differentially expressed (3-way ANOVA, p<0.05) including Ccl9, Ccl21, Ccl11, Csf1, and Il12b. For a complete list of proteins and other possible interactions please see supplemental Table 3 .
At the later time points, high-fat diet also stimulated an inflammatory response in C57Bl/6 wild-type mice, as represented by elevated serum levels for a number of inflammatory markers (Fig. 2) . C3H/HeJ mice, on the other hand, had the lowest levels of inflammatory markers, even when on high-fat diet. This finding is consistent with observations from our prior study comparing the aortic vascular wall gene expression in C3H/HeJ mice to that of C57Bl/6J mice. That study concluded C57Bl/6J mice have a higher genetic propensity for the expression of inflammatory markers in atherosclerosis.
Identification of time-specific protein expression signature pattern in mouse serum
Classification approaches to human cancer have provided significant insights regarding the clinical features of the tumor, including propensity to metastasis, drug responsiveness, and long term prognosis (13, 23, 33, 43). For atherosclerosis, the clinical utility of classification algorithms will be in prediction of future events. In a previous study we have applied classification algorithms to establish a panel of genes whose expression in the vessel wall could accurately classify
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disease severity in atherosclerotic vascular tissue derived from both mouse and human (45). In the current study we have employed a similar approach to identify a minimal subset of serum proteins to accurately classify each proteomic experiment with one of four defined stages of atherosclerosis in mice (Fig. 3) . Here we utilized several well-known classification algorithms to identify the variables that can best distinguish between the mice with different disease states.
These algorithms included Recursive Feature Elimination (RFE), Support Vector Machine (SVM), and Analysis of variance (ANOVA). We also used the Prediction Analysis of Microarray (PAM) as an additional classification algorithm. These algorithms rank the proteins based on their utility for class discrimination between time points 0, 10, 24, and 40 weeks in apoE mice on high-fat diet.
Our results demonstrated that a small subset of proteins (Ccl21, Ccl9, Csf3, Tnfsf11, Vegfa, Ccl11, Ccl2) were identified by a majority of the algorithms (Fig. 3A) . The predictive power of the signature pattern of this panel was superior to any single marker since no individual marker was able to accurately classify the various disease states (analysis not shown). To determine the utility of serum levels of these proteins for classification of mice with different disease states, we utilized the SVM algorithm (Linear Kernel) to generate a confusion matrix using cross-validation with repeated splits into 75% training and 25% test sets. This algorithm demonstrated that the signature pattern of expression of these serum proteins can distinguish groups of mice with and without disease with up to 100% accuracy (Fig. 3B) . Mice with intermediate stages of the disease are also distinguished from the other stages with a high degree of accuracy (79.6-100%) ( Figure   3B ).
Cross validation and Analysis of independent datasets.
A key proof of the utility of a defined set of classifier proteins is their ability to correctly classify data from an independent experiment. To validate the utility of the classifier proteins, we investigated their ability to accurately categorize an independent group of 16 week old apoE deficient mice. Using the SVM classification algorithm we were able to accurately classify each of
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the replicate experiments with the correct stage of the disease process (Fig. 3C) . As indicated by the greatest correlation between protein expression in this independent group of mice and protein expression patterns in the original experimental group aged 10 weeks, the classifier proteins accurately matched this validation dataset to the closest time-point in the training set. It is important to note that in this analysis the independent data set ("test") was not included in the training set ("known").
Biomarker serum protein levels correlate with vascular wall gene expression levels
Those biomarkers whose circulating protein levels correlate with molecular events and expression levels in the vessel wall are expected to be most informative about vascular disease. To investigate such correlations, and to gain insights from the biomarker data regarding the pathophysiology of atherosclerosis, we have investigated vascular wall gene expression patterns for genes encoding informative biomarkers. Using quantitative real-time reverse transcriptase polymerase chain reaction we were able to correlate serum protein levels of several markers with their vascular RNA expression. Among the markers studied, Ccl21 (r=0.91), Ccl2 (r=0.97), Ccl19 (r=0.80) and Ccl11 (r=0.67) revealed a remarkably high correlation between time related increase in gene expression and in serum levels (Fig. 4B ). Although these data do not exclude expression of these markers in other tissues, they suggest that expression is particularly associated with the atherosclerotic vascular wall.
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Discussion
There is an obvious need for improved tools to diagnose and treat pre-clinical atherosclerosis.
At present, although insights into mechanisms and circumstances of atherosclerosis are increasing, our methods for identifying the high-risk patients and predicting efficacy of measures to prevent coronary artery disease are still inadequate. Due to lack of highly sensitive and specific biomarkers for atherosclerotic disease, the first clinical presentation of more than half of these patients is either myocardial infarction or death (19, 20) . Several inflammatory markers have been studied in the context of atherosclerosis both in mice and humans and the results have strengthened the inflammatory hypothesis of atherosclerosis (38) . However, each study has focused on only a few individual markers, some lack longitudinal design, and only a few demonstrate direct correlation with gene expression at the vascular level (25, 29, 34).
Currently, the general markers of inflammation, although proposed for use in risk stratification of patients with atherosclerotic disease, are not used in screening of asymptomatic patients for accurate disease classification and more importantly for prediction of first cardiovascular events. The lack of specificity of markers such as C-reactive protein (CRP) and fibrinogen may stem from the fact that they are not derived from the vasculature and may signal inflammation in any organ. It is also possible that due to heterogeneity among the population at risk, a single marker cannot provide sufficient information for accurate prediction of disease. For similar reasons, these general markers of inflammation such as CRP and sedimentation rate (ESR) have been long abandoned as specific diagnostic markers in other inflammatory diseases such as lupus (SLE) and rheumatoid arthritis (RA).
We have shown previously with RNA profiling studies of mouse aortic tissues, with the same experimental design as that used here, that it is possible to identify a small number of genes capable of classifying disease severity (45). Obviously, given that the vascular tissue is not readily accessible, identification of protein markers in the serum can have practical implications in developing diagnostic tools for diagnosis of CAD in humans. In the work
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reported here, we have investigated inflammatory serum biomarker abundance patterns and investigated whether a subset of these biomarkers can be used to classify animals with respect to disease progression. Scientifically, these two types of information are complementary, and provide significantly greater insights into the detailed molecular mechanisms of the disease, from gene transcription to translation to intracellular pathways to secretion of mediators into the serum. As noted above, identification of the serum marker profile for a given disease state allows the development of non-invasive diagnostic approaches that can be used in humans.
Because we also have a detailed microarray based picture of the transcriptional landscape in the diseased tissue, we can use this view to assess upstream components in the pathways that lead to inflammatory mediator expression, the first step in developing highly targeted therapeutics. Indeed, serum assays such the one described here can then be used to assay the ultimate effects of such therapeutics.
We utilized protein microarrays for simultaneous protein expression profiling of sera from various mouse models of atherosclerosis with different susceptibilities and severity of atherosclerosis. Using classification algorithms similar to those utilized in classifying cancer progression and type, we were able to show that the unique signature patterns of these vascular-derived biomarkers could accurately predict different severity of atherosclerotic disease in mice.
In the prior study (45) our analysis revealed that the microarray gene expression profile of the independent data set derived from the 16 week time-point associated more closely with the 24 week time point whereas in the present study the protein profiles of the similar time point correlated more closely with the 10 week time-point. This finding may offer a number of interesting hypotheses. Given the limited number of probes in the current protein microarray, the protein classifiers in the current study are different from the gene classifiers identified in the prior study. It is also possible that time-related increase in serum protein expression lags behind changes at the level of vascular wall gene expression.
Since there may not be a direct correlation between vascular gene expression and serum protein levels for the same markers due to various factors such as post transcriptional modification and protein stability, an important validation of these data was the demonstration of disease-related vascular gene expression for a subset of these markers. We show a correlation between the time-related serum levels of these markers and their gene expression in the vessel wall. The time-dependent correlation of disease progression and vascular gene expression suggest that the primary site of marker production is the vessel wall. However, the vasculature may not be the sole source of the inflammatory markers and it is possible that other tissues such as muscle, spleen, adipose tissue, or liver may contribute to the serum levels of these markers, as suggested by previous reports (22). One marker evaluated in our studies, Il6, is known to be produced in muscle and liver as well as the vascular wall. Interestingly, the serum abundance of Il6 did not correlate with the temporal development of disease, correlating only weakly with gene expression in the vascular wall. These findings suggest that other tissues may contribute to serum levels of some markers, such as Il6, but that the levels of these were not correlated with the disease state we are studying and do not contribute to the classification panel.
The serum level of some of the systemic inflammatory markers may also be confounded by differences in metabolic parameters among the various mice studied. It has been demonstrated that a high-fat diet stimulates an inflammatory response in the liver (22). The level of expression of these genes remains high throughout the high-fat feeding period. We controlled for these systemic effects by comparing mice fed high-fat diets during both the early and late atherosclerosis stages, so that serum lipid levels are constant (14) , but the degree of atherosclerosis changes. These metabolic parameters therefore have a poor correlation with serum level of markers which demonstrate a linear increase with time. Thus, temporal changes in vascular derived markers serum levels correlate more closely with degree of atherosclerosis and not lipid levels.
The markers identified in this study provide strong support for the inflammatory nature of atherosclerosis and the individual markers identified offer some insights into the underlying mechanisms of disease in mice. These markers include important chemokines specific for both macrophages and T-cells. Ccl21 (originally Exodus-2/SLC/6Ckine/TCA4) is the most powerful chemoattractant for T-cells yet identified, and plays an important role in T-cell adhesion and trafficking from the vasculature to tissues sites of inflammation (30). Related chemokines Cxcl12 and Ccl19, also expressed at high levels in our experiments, mediate the firm adherence of Tcells to the endothelium by stimulating LFA-1 (6, 15). Importantly, Ccl21 is not thought to play a role in T-cell effector function during a normal immune response but has been found to be highly induced in endothelial cells in T-cell mediated autoimmune diseases (8). Therefore, the novel finding of disease-related high level circulating Ccl21, and highly correlated expression of CCL21 in the diseased vessel wall, raises the question whether autoimmune pathways may play a role in development of atherosclerosis in mice (44). CCL21 levels in human disease remains to be measured. Ccl19 (MIP-3b) is somewhat similar function to Ccl21. It binds the same receptor, Ccr7, and is a potent chemoattractant for both T-cells and B-cells. But unlike Ccl21, it appears to also play a role in normal T-cell function. Its expression in the atherosclerotic vasculature and the high correlation between serum levels and aortic gene expression are both novel findings.
The roles of Ccl2 (Mcp1 or JE) (3) and Ccl11 (Eotaxin) (10, 17) in atherosclerosis are well established and confirm our findings. We have also documented that the serum levels of both Cxcl2 (MIP-2) and Cxcl1 (KC) are elevated in sera of atherosclerotic mice, consistent with serum levels described by other investigators (29). As described in that study, we found levels of Cxcl2 (MIP-2) to be less reliable. Moreover, given the lower correlation of serum levels with aortic gene expression, it appears that significant amounts of Cxcl2 may be produced by non-vascular tissues, confirming previous observations (29). Nonetheless, we found that the correlation with vascular gene expression of Cxcl2 was still better than other markers such as Il6 and Csf3.
Despite the increased levels of Cxcl1 (KC), we did not find this marker to be a consistent predictor
of disease, which is consistent with a recent study (34) . Vegfa has recently been described as an independent predictor of acute coronary syndrome (18, 24) . Our study supports Vegfa as a reasonable classifier in at least 3 of the algorithms used, confirming its potential utility in monitoring human disease. Another very interesting finding in our study is the role of Tnfsf11 (TRANCE) in atherosclerosis. Tnfsf11 is a member of TNF cytokine family and a ligand for osteoprotegerin which functions as key factor for osteoclast differentiation and activation. This protein is also known to be a dentritic cell survivor factor and is involved in the regulation of T-cell dependent immune response. Osteoprotegerin has recently been identified as a potential risk factor for progressive atherosclerosis and cardiovascular disease in humans (21, 37). Other cytokines that have been speculated to play a role in atherosclerosis include the Il12b (25) and Il5 (9). While, we demonstrated their serum level to be predictive of disease state, we failed to confirm vascular-specific expression of Il12b in atherosclerotic lesions.
In summary, the top serum protein classifiers identified in our study encompass a wide range of atherosclerotic biological process including macrophages chemoattraction (Ccl9, Ccl2), T-cell chemokine activity (Ccl21 and Ccl19), innate immunity (Il5), vascular calcification (Tnfsf11), angiogenesis (Vegfa), high fat induced inflammation (Cxcl1 and possibly leptin). The signature pattern derived from simultaneous measurement of these markers, which represent diverse atherosclerosis-related biological processes, will likely add to the specificity needed for diagnosis of atherosclerotic disease. Further validation of this approach with appropriate prospective trials in human subject may lead to improved screening diagnostic tools in atherosclerosis and coronary artery disease.
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45.
Tabibiazar The results are represented in tabular fashion with the confusion matrix as described in methods.
The notation "TRUE" refers to "Actual Disease State", whereas "Predicted" refers to "Predicted 
